Valion Bio, Inc. (VBIO)
2.50
-0.27
(-9.75%)
USD |
NASDAQ |
Sep 08, 16:00
2.45
-0.05
(-2.00%)
Pre-Market: 08:41
Valion Bio Price : 2.50 for Sept. 8, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 2.74 | 2.74 | 2.44 | 2.50 | 160321.0 |
| Sep 04, 2026 | 2.90 | 2.989 | 2.72 | 2.77 | 81045.00 |
| Sep 03, 2026 | 3.03 | 3.21 | 2.75 | 2.80 | 140237.0 |
| Sep 02, 2026 | 3.02 | 3.239 | 2.70 | 3.12 | 149619.0 |
| Sep 01, 2026 | 3.22 | 3.46 | 2.88 | 3.07 | 295666.0 |
| Aug 31, 2026 | 2.80 | 3.87 | 2.80 | 3.57 | 663058.0 |
| Aug 28, 2026 | 3.065 | 3.35 | 2.918 | 3.022 | 522472.0 |
| Aug 27, 2026 | 3.798 | 3.875 | 2.932 | 3.065 | 325237.0 |
| Aug 26, 2026 | 3.85 | 4.135 | 3.812 | 3.90 | 141056.0 |
| Aug 25, 2026 | 3.625 | 4.065 | 3.50 | 3.975 | 291955.0 |
| Aug 24, 2026 | 3.00 | 4.692 | 2.92 | 4.15 | 4.390M |
| Aug 21, 2026 | 2.962 | 3.30 | 2.79 | 3.065 | 156242.0 |
| Aug 20, 2026 | 3.312 | 3.312 | 2.875 | 3.052 | 199976.0 |
| Aug 19, 2026 | 3.302 | 3.415 | 2.825 | 3.36 | 497100.0 |
| Aug 18, 2026 | 4.50 | 4.50 | 3.80 | 4.015 | 431050.0 |
| Aug 17, 2026 | 4.295 | 5.98 | 4.165 | 4.562 | 1.098M |
| Aug 14, 2026 | 4.05 | 7.315 | 4.005 | 4.765 | 6.841M |
| Aug 13, 2026 | 4.00 | 5.125 | 3.985 | 4.27 | 944402.0 |
| Aug 12, 2026 | 8.332 | 32.50 | 5.00 | 5.65 | 5.508M |
| Aug 11, 2026 | 7.195 | 8.917 | 7.035 | 7.75 | 55234.00 |
| Aug 10, 2026 | 7.195 | 7.49 | 6.875 | 7.20 | 4615.00 |
| Aug 07, 2026 | 7.072 | 8.335 | 6.565 | 7.135 | 45139.00 |
| Aug 06, 2026 | 7.50 | 8.00 | 6.50 | 6.872 | 32186.00 |
| Aug 05, 2026 | 8.372 | 8.565 | 7.125 | 7.312 | 12808.00 |
| Aug 04, 2026 | 8.15 | 9.24 | 7.998 | 8.308 | 25435.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Outlook Therapeutics, Inc. | 0.6405 |
| Agenus, Inc. | 7.43 |
| Amgen, Inc. | 393.17 |
| Anika Therapeutics, Inc. | 21.04 |
| BioCryst Pharmaceuticals, Inc. | 9.065 |
Price Related Metrics
| PS Ratio | 1.450 |
| Price to Book Value | 0.0978 |
| Earnings Yield | -8.41K% |
| Market Cap | 0.4153M |